Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Vasc Interv Radiol ; 21(9): 1359-63, 2010 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-20688533

RESUMO

PURPOSE: To study retrospectively the prognostic factors for acute basilar artery occlusion treated with intraarterial thrombolysis and stent placement. MATERIALS AND METHODS: Within 3-48 hours of disease onset, 52 patients with basilar artery occlusion were treated with emergency intraarterial thrombolysis with recombinant tissue plasminogen activator (rtPA) or urokinase (UK) or intraarterial thrombolysis combined with stent placement. Sixteen patients simultaneously received stent placement for the partial recanalization of basilar artery occlusion after intraarterial thrombolysis. The National Institutes of Health Stroke Scale (NIHSS) scores and the modified Rankin Scale (mRS) scores of the patients were estimated. RESULTS: A favorable clinical outcome occurred in 22 patients (42.3%), and 20 patients (38.5%) died. The survival rate was 61.5% (32 patients). Successful recanalization of basilar artery occlusion was achieved in 24 patients (46.2%), and partial recanalization was achieved in 16 patients (30.7%). The rate of recanalization was 76.9%. NIHSS scores less than 14, treatment time window less than 24 hours, and a good recanalization were markedly correlated with good clinical prognosis. NIHSS scores less than 14 and treatment time window less than 24 hours were significantly correlated with recanalization. NIHSS scores less than 14 and good recanalization could act as independent predictors for clinical prognosis. CONCLUSIONS: NIHSS scores less than 14 on admission and successful recanalization can predict favorable outcome for patients with basilar artery occlusion. This study shows that intraarterial thrombolysis and stent placement may be a useful treatment for acute basilar artery occlusion.


Assuntos
Angioplastia com Balão/instrumentação , Fibrinolíticos/administração & dosagem , Stents , Acidente Vascular Cerebral/terapia , Terapia Trombolítica , Insuficiência Vertebrobasilar/terapia , Doença Aguda , Adulto , Idoso , Angioplastia com Balão/efeitos adversos , Angioplastia com Balão/mortalidade , China , Terapia Combinada , Avaliação da Deficiência , Feminino , Fibrinolíticos/efeitos adversos , Humanos , Injeções Intra-Arteriais , Modelos Logísticos , Masculino , Pessoa de Meia-Idade , Razão de Chances , Proteínas Recombinantes/administração & dosagem , Estudos Retrospectivos , Medição de Risco , Fatores de Risco , Índice de Gravidade de Doença , Acidente Vascular Cerebral/tratamento farmacológico , Acidente Vascular Cerebral/mortalidade , Taxa de Sobrevida , Terapia Trombolítica/efeitos adversos , Terapia Trombolítica/mortalidade , Fatores de Tempo , Ativador de Plasminogênio Tecidual/administração & dosagem , Resultado do Tratamento , Ativador de Plasminogênio Tipo Uroquinase/administração & dosagem , Insuficiência Vertebrobasilar/tratamento farmacológico , Insuficiência Vertebrobasilar/mortalidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA